Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Combining antihistamines with topical treatment improves hair regrowth in alopecia areata.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Combining cetirizine and topical steroids can effectively manage severe lichen planus pilaris.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Micelles can change cetirizine's ionization, affecting its effectiveness in treatments.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Montelukast is linked to increased risks of suicidal thoughts and depression.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Upadacitinib improved multiple immune-related conditions in one patient.

Losartan can cause temporary loss of taste.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.